Advertisement

Anticipating the Diagnosis of Breast Cancer: Screening Controversies and Warning Dreams

  • Larry BurkEmail author
Chapter
  • 522 Downloads

Abstract

Mass population screening programs such as mammography represent an attempt to use technology to forecast the presence of disease in asymptomatic individuals. Unfortunately, sometimes the benefits outweigh the risks when there are too many false positives that require further invasive diagnostic procedures or when detection of carcinoma in situ leads to aggressive treatment of disease that may have never become clinically relevant. There are options of using other imaging approaches such MRI, ultrasound, and thermography, as well as offering genetic screening. It is also a timely opportunity to investigate an intuitive approach to self-care using dreams as a supplement to breast self-examination. A recent survey of 18 women, from around the world, who had life-changing warning dreams of breast cancer prior to symptoms that prompted medical attention leading directly to diagnosis will be reviewed.

Keywords

Breast cancer screening Dreams Precognition Magnetic resonance imaging Premonition Mammography Ultrasound BRCA genetic testing Thermography 

References

  1. 1.
    SEER Stat Fact Sheets: Breast Cancer. http://seer.cancer.gov/statfacts/html/breast.html
  2. 2.
    Biller-Andorno, N., Juni, P.: Abolishing mammography screening programs? A view from the Swiss Medical Board. NEJM 16 (2014) doi: 10.1056/NEJMp1401875 http://www.nejm.org/doi/full/10.1056/NEJMp1401875
  3. 3.
    Rebbeck, T.R., Friebel, T., Lynch, H.T., et al.: Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J. Clin. Oncol. 22, 1055–1062 (2004)CrossRefGoogle Scholar
  4. 4.
    Burk, L.: Breast cancer warning dreams pilot project: characteristics of prodromal dreams. In: Proceedings of the 31st Annual International Association for the Study of Dreams Conference, Berkeley, CA (2014)Google Scholar
  5. 5.
    Eberl, M.M., Fox, C.H., Edge, S.B., Carter, C.A., Mahoney, M.C.: BI-RADS classification for management of abnormal mammograms. J. Am. Board Fam. Med. 19, 161–164 (2006). doi: 10.3122/jabfm.19.2.161 CrossRefGoogle Scholar
  6. 6.
    Shapiro, S.: Evidence on screening for breast cancer from a randomized trial. Cancer 39(suppl 6), 2772–2782 (1977)CrossRefGoogle Scholar
  7. 7.
    Fletcher, S., Black, W., Harris, R., Rimer, B., Shapiro, S.: Report of the international workshop on screening for breast cancer. J. Natl. Cancer Inst. 85, 1621–1624 (1993)CrossRefGoogle Scholar
  8. 8.
    U.S. Preventive Services Task Force. Screening for Breast Cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 17, 151(10), 716–726, W-236 (2009). doi: 10.7326/0003-4819-151-10-200911170-00008. http://www.guideline.gov/content.aspx?id=15429
  9. 9.
    Mainiero, M.B., et al.: ACR appropriateness criteria breast cancer screening. J. Am. Coll. Radiol. 10(1); 11–14 (2013). doi: 10.1016/j.jacr.2012.09.036. http://www.acr.org/~/media/ACR/Documents/AppCriteria/Diagnostic/BreastCancerScreening.pdf
  10. 10.
    Gøtzsche, P.C., Nielsen, M.: Screening for breast cancer with mammography. Cochrane Database Syst. Rev. 19(1), CD001877. (2011) doi: 10.1002/14651858.CD001877.pub4
  11. 11.
    Welch, H.G., Schwartz, L., Woloshin, S.: Overdiagnosed: Making People Sick in the Pursuit of Health. Beacon Press, Boston (2011)Google Scholar
  12. 12.
    Zackrisson, S., Andersson, I., Janzon, L., Manjer, J., Garne, J.P.: Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 332(7543), 689–692 (2006). Epub 3Google Scholar
  13. 13.
    Welch, H.G., Black, W.C.: Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann. Intern. Med. 127(11), 1023–1028 (1997)Google Scholar
  14. 14.
    Gofmann, J.W.: Preventing Breast Cancer: The Story of a Major, Proven, Preventable Cause of This Disease. Committee for Nuclear Responsibility, San Francisco (1996)Google Scholar
  15. 15.
    Hefti, R.: The Mammogram Myth: the independent investigation of mammography the medical profession doesn’t want you to know about. Amazon Digital Services, Rolf Hefti (2013)Google Scholar
  16. 16.
    Miller, A.B., Wall, C., Baines, C.J., Sun, P., To, T., Narod, S.A.: Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National breast screening study: randomised screening trial. BMJ 348 (2014). doi:http://dx.doi.org/10.1136/bmj.g366 (Published 11 February 2014) http://www.bmj.com/content/348/bmj.g366
  17. 17.
    Kopans, D.B.: Arguments against mammography screening continue to be based on faulty science. Oncologist 19(2), 107–112 (2014). doi: 10.1634/theoncologist.2013-0184. https://theoncologist.alphamedpress.org/content/19/2/107.full.pdf+html
  18. 18.
    Tabár, L., Vitak, B., Yen, M.F., Chen, H.H., Smith, R.A., Duffy, S.W.: Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J. Med. Screen. 11(3), 126–129 (2004)CrossRefGoogle Scholar
  19. 19.
    Webb, M.L., Cady, B., Michaelson, J.S., et al.: A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer 120(18), 2839–2846 (2014)CrossRefGoogle Scholar
  20. 20.
    Kopans, D.B.: Digital breast tomosynthesis from concept to clinical care. AJR 202(2), 299–308 (2014). doi: 10.2214/AJR.13.11520 CrossRefGoogle Scholar
  21. 21.
    Berlin, L., Hall, F.M.: More mammography muddle: emotions, politics, science, costs, and polarization. Radiology 255(2), 311–316 (2010). doi: 10.1148/radiol.10100056 CrossRefGoogle Scholar
  22. 22.
    Fakhran, S., Alhilali, L., Kale, H., Kanal, E.: Assessment of rates of acute adverse reactions to gadobenate dimeglumine: review of more than 130,000 administrations in 7.5 years. AJR 204, 703–706. (2015) http://www.ajronline.org/doi/abs/10.2214/AJR.14.13430
  23. 23.
    Schlaudecker, J.D., Bernheisel, C.R.: Gadolinium-induced nephrogenic systemic fibrosis. Am. Fam. Physician 80(7), 711–714. (2009) http://www.aafp.org/afp/2009/1001/p711.html
  24. 24.
    McDonald, R.J., McDonald, J.S., Kallmes, D.F., Jentoft, M.E., Murray, D.L., Thielen, K.R., Williamson, E.E., Eckel, L.J.: Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 5, 150025 (2015). [Epub ahead of print] http://dx.doi.org/10.1148/radiol.15150025
  25. 25.
    Kuhl, C.K., et al.: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high Familial risk for breast cancer. JCO 23(33), 8469–8476 (2005). http://jco.ascopubs.org/content/23/33/8469.long
  26. 26.
    Berg, W.: How well does supplemental screening magnetic resonance imaging work in high-risk women? JCO 32(21), 2193–2196 (2014)CrossRefGoogle Scholar
  27. 27.
    National Comprehensive Cancer Network Genetics Screening. http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
  28. 28.
    Berg, W.A., Blume, J.D., Adams, A.M., et al.: Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology 254, 79–87 (2010)CrossRefGoogle Scholar
  29. 29.
    Berg, W.A., et al.: Combined screening with ultrasound and mammography vs. mammography alone in women at elevated risk of breast cancer. JAMA 299(18), 2151–2163 (2008). http://jama.jamanetwork.com/article.aspx?articleid=181896
  30. 30.
    Corsetti, V., Houssami, N., Ferrari, A., et al.: Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur. J. Cancer 44, 539–544 (2008)CrossRefGoogle Scholar
  31. 31.
    Moskowitz, M.: Screening for breast cancer: how effective are our tests? A critical review. CA-A Cancer J. Clin. 33(1), 26–39 (1983). http://onlinelibrary.wiley.com/doi/10.3322/canjclin.33.1.26/pdf
  32. 32.
    Amalu, W.C., Hobbins, W.B., Head, J.F., Elliot, R.L.: Infrared imaging of the breast: an overview. In medical devices and systems. CRC/Taylor & Francis, Boca Raton, FL (2006)Google Scholar
  33. 33.
    Hudson, T.: Journey to Hope: Leaving the Fear of Breast Cancer Behind. Brush and Quill Productions, Naples, FL (2011)Google Scholar
  34. 34.
    Pollack, A.: New genetic tests for breast cancer hold promise. The New York Times, April 21 (2015). http://www.nytimes.com/2015/04/21/business/more-accurate-affordable-tests-for-detecting-breast-cancer-genes.html?_r=1
  35. 35.
  36. 36.
    Shiovitz, S., Korde, L.A.: Genetics of breast cancer: a topic in evolution. Ann. Oncol. (2015). doi: 10.1093/annonc/mdv022 Google Scholar
  37. 37.
  38. 38.
    Phillips, K.A., Milne, R.L., Rookus, M.A., et al.: Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JCO 31(25), 3091–3099 (2013)CrossRefGoogle Scholar
  39. 39.
    Sigerist, H.E.: A History of Medicine, Volume 2: early Greek, Hindu, and Persian Medicine, 1st edn. Oxford University Press, New York (1987)Google Scholar
  40. 40.
    Krippner, S.: Humanity’s first healers: psychological and psychiatric stances on shamans and shamanism. Rev. Psiq. Clin. 34S(1), 16–22 (2007)Google Scholar
  41. 41.
    Kasatkin, V.N.: Teoriya Snovidenii (Theory of Dreams). Meditsina, Leningrad (1967)Google Scholar
  42. 42.
    Van de Castle, R.L.: Our Dreaming Mind. Ballantine Books, New York (1994)Google Scholar
  43. 43.
    Royston, R., Humphries, A.: The Hidden Power of Dreams. Bantam Books, London (2006)Google Scholar
  44. 44.
    Barasch, M.I.: Healing Dreams: Exploring the Dreams That Can Transform Your Life. Riverhead Books, New York (2000)Google Scholar
  45. 45.
    Kinney, C.K.: Transcending breast cancer: reconstructing one’s self. Issues Mental Health Nurs. 17, 201–216 (1996)CrossRefGoogle Scholar
  46. 46.
    Burk, L.: Prodromal dreams of breast cancer and clinical correlation. In: Proceedings of the IASD Psiber dreaming Conference (2013). http://www.letmagichappen.com/images/uploads/documents/pdc2013-burk.BreastCancerDreams.pdf
  47. 47.
    Lee-Shield, S.: My Appeal. July 4 (2013). http://soniaslifeappeal.wordpress.com/myappeal/
  48. 48.
    Dossey, L.: One Mind: How Our Individual Mind Is Part of a Greater Consciousness and Why It Matters. Hay House Inc, Carlsbad, CA (2013)Google Scholar
  49. 49.
    Burch, W.E.: She Who Dreams: A Journey Into Healing Through Dreamwork. New World Library, Novato, CA (2003)Google Scholar
  50. 50.
    O’Keefe-Kanavos, K.: Surviving Cancerland: Intuitive Aspects of Healing. Cypress House, Fort Bragg, CA (2014)Google Scholar
  51. 51.
  52. 52.
    Burk, L.: Warning dreams preceding the diagnosis of breast cancer: a survey of the most important characteristics. Explore 11(3), 193–198 (2015). doi: 10.1016/j.explore.2015.02.008. Epub 2015 Feb 14CrossRefGoogle Scholar
  53. 53.
    Nadin, M.: Anticipation across disciplines. Cognitive Systems Monographs, Vol. 29. Springer, Cham, CH (2015). http://www.springer.com/us/book/9783319225982
  54. 54.
    Dossey, L.: Nonlocal knowing: the emerging view of who we are. Explore 4(1), 1–9 (2008). http://www.explorejournal.com/article/S1550-8307%2807%2900414-4/fulltext#sec5
  55. 55.
    Yee, K.M.: USPSTF mammo recs would cut coverage for 17M women. AuntMinnie.com. May 14 (2015). http://www.auntminnie.com/index.aspx?sec=sup&sub=imc&pag=dis&ItemID=110963&wf=6529

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Healing Imager, P.CDurhamUSA

Personalised recommendations